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Cytokine-Induced Nitric Oxide Inhibits Bone Resorption
by Inducing Apoptosis of Osteoclast Progenitors and
Suppressing Osteoclast Activity
ROBERT J. VAN ’T HOF and STUART H. RALSTON
ABSTRACT
Interferon-g (IFN-g) has been shown to inhibit interleukin-1 (IL-1) and tumor necrosis factor a (TNF-a)
stimulated bone resorption by strongly stimulating nitric oxide (NO) synthesis. Here we studied the mechanisms
underlying this inhibition. Osteoclasts were generated in 10-day cocultures of mouse osteoblasts and bone marrow
cells and the effect of cytokine-induced NO on osteoclast formation and activity was determined. Stimulation of the
cocultures with IL-1b, TNF-a and IFN-g markedly enhanced NO production by 50- to 70-fold, and this was found
to be derived predominantly from the osteoblast cell layer. When high levels of NO were induced by cytokines
during early stages of the coculture, osteoclast formation was virtually abolished and bone resorption markedly
inhibited. Cytokine stimulation during the latter stages of coculture also resulted in inhibition of bone resorption,
but here the effects were mainly due to an inhibitory effect on osteoclast activity. At all stages, however, the
inhibitory effects of cytokines on osteoclast formation and activity were blocked by the NO-synthase inhibitor
L-NMMA. Further investigations suggested that the NO-mediated inhibition of osteoclast formation was due in
part to apoptosis of osteoclast progenitors. Cytokine stimulation during the early stage of the culture caused a
large increase in apoptosis of bone marrow cells, and these effects were blocked by L-NMMA and enhanced by NO
donors. We found no evidence of apoptosis in osteoblasts exposed to high levels of cytokine-induced NO at any
stage in the culture, however, or of apoptosis affecting mature osteoclasts exposed to high levels of NO, suggesting
that immature cells in the bone marrow compartment are most sensitive to NO-induced apoptosis. In summary,
these studies identify NO as a potentially important osteoblast-osteoclast coupling factor which has potent
inhibitory effects on bone resorption. These actions, in turn, are mediated by inhibition of osteoclast formation
probably due to NO-induced apoptosis of osteoclast progenitors and by inhibition of the resorptive activity of
mature osteoclasts. (J Bone Miner Res 1997;12:1797–1804)
INTRODUCTION
NITRIC OXIDE (NO) is a free radical that has been shownto play an important role in the regulation of vascular
tone, platelet function, neurotransmission, and immune
function.(1) An action of NO that is the source of increasing
interest is as a mediator of bone cell function.(2) Proinflam-
matory cytokines such as interleukin-1 (IL-1), tumour ne-
crosis factor (TNF), and interferon gamma (IFN-g) have
potent effects on bone remodeling(3) and are also powerful
stimulators of NO production in bone cells,(4–6) raising the
possibility that NO may act as a mediator of cytokine effects
on bone turnover. In keeping with this hypothesis, NO has
been found to be an important modulator of osteoclastic
bone resorption. At low concentrations, NO acts to poten-
tiate IL-1–induced bone resorption,(7) and evidence has
been presented to suggest that constitutive production of
small amounts of NO may be necessary for normal osteo-
clast function.(8) High concentrations of NO strongly inhibit
bone resorption, however, both in organ cultures(7,9) and in
cultures of isolated osteoclasts.(8,10,11) While high levels of
NO have been shown to be responsible for the inhibitory
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effect of IFN-g on IL-1 and TNF-a stimulated bone resorp-
tion,(7,9) the mechanisms by which NO exerts its effects on
the osteoclast remain unclear.
To define these mechanisms, we studied the effects of
cytokine-induced NO production in cocultures of mouse
calvarial osteoblasts and bone marrow cells.(12) In this sys-
tem, fully differentiated and actively resorbing osteoclasts
form over a 10-day culture period, thus permitting a de-
tailed analysis of the relative effects of NO on osteoclast
formation and activity.
MATERIALS AND METHODS
Isolation and culture of cells
The bone marrow–osteoblast coculture system used is an
adaptation of that described by Takahashi et al.(12) Calvar-
ial bones were dissected from 2-day-old Balb/C mice and
treated for 15 minutes with 1 mg/ml collagenase type I
(Sigma Chemical Co., St. Louis, MO, U.S.A.) in Hank’s
balanced salt solution (HBSS). The supernatant was dis-
carded and the calvariae were digested with collagenase for
another 30 minutes. The resulting cell suspension was re-
moved, and the cells were resuspended in culture medium
(a-MEM, supplemented with 10% fetal calf serum [FCS]
and penicillin/streptomycin). The calvariae were washed in
phosphate buffered saline (PBS) and treated for 15 minutes
with 4 mM EDTA in PBS followed by a third 30-minute
collagenase digestion. Both of the resulting cell suspensions
were spun down and resuspended in culture medium, and
all three cell suspensions were pooled. The cells were al-
lowed to adhere to a 75 cm2 tissue culture flask, nonadher-
ent cells were removed, and the remaining cells cultured
overnight in culture medium at 37°C and 5% CO2, rinsed
with PBS and harvested by trypsin digestion. The resulting
cell population consisted predominantly of osteoblasts;
.90% of the cells stained positive for alkaline phosphatase,
less than 0.1% of the cells stained positive for the macro-
phage marker acid phosphatase, and none of the cells
stained positive for the endothelial marker von Willebrand
Factor.
A bone marrow cell population containing osteoclast
precursors was isolated from the long bones of 3- to 5-
month-old Balb/C mice, by flushing marrow from dissected
long bones with a syringe and a 25 gauge needle using
HBSS supplemented with 10% FCS. Erythrocytes were
removed by Ficoll Hypaque density gradient centrifugation,
and the remaining bone marrow cells were washed with
PBS, spun down, and resuspended in culture medium.
Cocultures of osteoblasts and bone marrow cells were
performed in either 48- or 96-well tissue culture plates. In
96-well plates, the osteoblasts and bone marrow cells were
plated at 104 cells/well and 2 3 105 cells/well, respectively,
in 150 ml of a-MEM supplemented with 10% FCS, antibi-
otics, and 10 nM 1,25-dihydroxyvitamin D3. In 48-well
plates, double the amount of cells and culture medium were
used. At the end of the culture period, osteoclasts were
identified by tartrate resistant acid phosphatase (TRAP)
staining and resorption pits by reflected light microscopy
(see below). In some experiments, calvarial osteoblasts
were replaced by UMR 106 osteoblast-like cells, plated at
the same density.
In the coculture system, formation of osteoclasts can be
divided in three different stages. During the first 3 days, no
TRAP positive mono- or multinucleated cells are observed.
Subsequently (days 4–7), TRAcP positive cells start to ap-
pear and the first resorption pits are usually detected at day
5 or 6, and later still (days 7–10), large numbers of multinu-
cleated TRAcP positive multinucleated cells (MNCs) are
present and extensive resorption takes place.
Tartrate resistant acid phosphatase staining
Cultures were fixed for 10 minutes in buffered formalin
(pH 7.4), washed with PBS, and incubated with naphtol-
ASBI-phosphate, hexazotized pararosanilin, and 30 mM
tartrate in acetate buffer (pH 5.5) at 37°C for 30 min-
utes.(13) The cultures were washed with PBS and the num-
ber of osteoclasts, defined as TRAP positive stained
multinucleated (.3 nuclei/cell) cells, were counted.
Analysis of resorption pits
Osteoblasts and bone marrow cells were cocultured on
top of dentine slices (elephant tusk, 4 mm diameter) in
96-well plates as described above. At the end of the culture
period, the cells were removed from the dentine slices and
the resorption pits examined directly by reflected light
microscopy. The area of resorption was measured using
a Leitz Q500MC image analysis system (Leitz, Milton
Keynes, U.K.).
Nitric oxide production
NO production was assessed by measuring the stable end
product of NO, nitrite, in the culture medium using the
Griess reaction as described previously.(4)
Detection of apoptosis
Apoptotic cells were identified by typical appearances on
light and electron microscopy and by the TUNEL (TdT-
mediated X-dUTP nick end labeling) assay, using a kit
obtained from Appligene Oncor (Chester-Le-Street, U.K.).
For the TUNEL assay, cocultures were performed as de-
scribed above in tissue culture chambers, and at the end of
the culture period the cells were fixed in 4% paraformal-
dehyde. The cultures were then incubated with terminal
deoxy/nucleotidyl transferase and digoxigenin (DIG)-la-
beled nucleotides according to the manufacturer’s instruc-
tions. Apoptotic DIG-labeled nuclei were identified using a
fluoresceinisothiocyanate (FITC)-labeled anti-DIG anti-
body. In some studies, apoptosis was also quantitated using
a commercially available kit, which measures DNA frag-
mentation by an enzyme-linked immunosorbent assay
(ELISA) (Boehringer Mannheim, Lewes, U.K.). Osteo-
blasts and bone marrow cells were incubated overnight with
the thymidine analog 5-bromo-29-deoxy-uridine (BrdU).
Subsequently, the cells were cocultured for varying periods
and all the cells lysed with a nonionic detergent. The ELISA
1798 VAN ’T HOF AND RALSTON
(which detects BrdU-labeled DNA fragments) was per-
formed according to the manufacturer’s instructions, and
apoptosis (in arbitrary units) was expressed as absorbance
at 540 nm using 690 nm as the reference wavelength. BrdU
labeling efficiency of the osteoblast and bone marrow cell
populations was similar (.95%) as determined by immu-
nocytochemical labeling (data not shown).
Statistics
Student’s t-test was used in statistical evaluation, and
differences were scored as significant when the two-tailed p
value was less than 0.05.
RESULTS
Cytokines stimulate NO production in cocultures
Stimulation of the cultures with cytokines led to a mod-
erate induction of NO synthesis by IL-1b and TNF-a and
strong stimulation by IFN-g (Fig. 1a). There was signifi-
cantly greater stimulation of NO production with combina-
tions of two cytokines, and the highest amounts were pro-
duced upon stimulation of the cells with all three cytokines
(cocktail). Irrespective of the stimulus, NO synthesis was
significantly inhibited by the competitive nitric oxide syn-
thase (NOS) inhibitor L-NG-monomethyl-L-arginine (L-
NMMA) (Fig. 1b). When osteoblasts and bone marrow
cells were cultured separately and exposed to the cytokine
cocktail, both could be stimulated to produce NO, although
the amount of NO (measured as medium nitrite) produced
per cell was more than 100-fold greater in the osteoblasts
(118 pmol/cell/h) than in the bone marrow cells (0.83 pmol/
cell/h). This was reflected by the fact that the osteoblast
monocultures produced much more NO than bone marrow
monocultures and almost as much NO as the cocultures
(Fig. 1b), even though the bone marrow monocultures and
cocultures contained approximately 20 times more cells
than the osteoblast cultures. Taken together, these data
suggest that, in the coculture system, cytokine-induced pro-
duction of NO is predominantly derived from osteoblast-
like cells. Basal and cytokine-stimulated NO production did
not differ significantly in parallel cultures which were per-
formed on plastic as opposed to those cultured on dentine
(compare for example, NO2 levels in Figs. 1a and 1b [plas-
tic] with those in Fig. 2c [dentine]).
Effects of cytokine-induced NO on osteoclast
formation and activity
When the cytokine cocktail was added during the early
stages of osteoclast development (days 4–7), hardly any
osteoclasts formed (Fig. 2a) and pit formation (measured at
day 10, Fig. 2b) was almost completely inhibited. Both
effects were partially reversed when NO production was
blocked by the NOS inhibitor L-NMMA, indicating that
NO was largely responsible for the effects observed. When
the cultures were cytokine stimulated at a later stage in the
culture, by which time many osteoclasts had already formed
(days 7–10), a small increase in osteoclast number was
observed compared with controls (Fig. 2a) but there was a
significant decrease in resorption area (Fig. 2b), indicating
less resorption per osteoclast. Simultaneous addition of
L-NMMA at this stage led to a further increase in the
number of osteoclasts and a marked increase of bone re-
sorption. Taken together, these results indicate that cyto-
kine-induced NO production exerts a powerful inhibitory
effect on osteoclast formation at all stages of the culture but
demonstrates that when NO is induced during the later
stages of culture, there is an additional inhibitory effect of
NO on resorptive activity of mature (preformed) oste-
oclasts. The differential effects on osteoclast formation
and activity did not appear to be due to major differences
FIG. 1. Cytokine-stimulated NO production by cocultures
is mainly derived from osteoblasts. Osteoblasts and bone
marrow cells were isolated and cultured for 2 days as de-
scribed in the Materials and Methods section, cytokines
were then added and medium nitrite levels measured after
a further 48 h. (a) Cocultures of osteoblasts and bone
marrow cells stimulated with cytokines as indicated (IL-1,
10 U/ml; TNF, 25 ng/ml; IFN, 100 U/ml). (b) Osteoblast
cultures, bone marrow cultures, and cocultures were set up
separately and stimulated with cytokine mix (IL-1, 10 U/ml;
1TNF, 25 ng/ml; 1IFN, 100 U/ml) in the presence and
absence of the NOS-inhibitor L-NMMA (1 mM). The re-
sults shown are from a representative experiment from at
least three performed, with three replicates per group. *p ,
0.05, **p , 0.01 from control, 11p , 0.01 from no
L-NMMA.
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between the degree of NO stimulation at different stages
in the culture since NO2 levels were only marginally
higher in cultures stimulated with cytokines between days
7–10 as compared with those stimulate between days 4 –7
(Fig. 2c).
NO induces apoptosis of bone marrow cells
in cocultures
Large numbers of cell fragments were observed in the
nonadherent (bone marrow-derived) cell layer in cocultures
that had been stimulated with the cytokine cocktail,
whereas these effects were not observed in control cultures
(Fig. 3). Since cellular fragmentation is a feature of apo-
ptosis, we decided to investigate the possibility that cyto-
kine-induced NO production was inhibiting osteoclast for-
mation by causing apoptosis of osteoclast progenitors.
Large numbers of apoptotic cells were identified by
TUNEL staining in the nonadherent bone marrow cell
layer, and the presence of apoptosis was confirmed by
electron microscopy (Fig. 4), which demonstrated typical
features, including nuclear fragmentation, and nuclear and
cellular condensation. A large increase in apoptosis as mea-
sured by a DNA fragmentation ELISA was also observed in
the nonadherent cell layer after cytokine stimulation and
this was reversed by the addition of L-NMMA (Fig. 5). It is
important to emphasize that cytokine-induced apoptosis
was only observed in cocultures and not in single cultures of
either osteoblasts or bone marrow cells (Fig. 5) which sug-
gests that the high levels of NO produced by osteoblasts in
the cocultures are necessary for apoptosis to occur. Indeed,
the low basal level of apoptosis, which was present in bone
marrow cells cultured in the absence of osteoblasts, was
significantly decreased by treatment with the cytokine cock-
tail. Cytokine-induced apoptosis was noted to a similar
extent in cocultures performed on plastic and on dentine
slices (data not shown).
To investigate the possibility that factors specific to the
coculture system such as osteoblast–bone marrow contact
may have contributed to the apoptotic effects of cytokines,
we performed further studies in which murine bone marrow
cells were cocultured with UMR 106 osteoblast-like cells in
place of calvarial osteoblasts, since our previous studies had
shown that UMR 106 cells do not produce significant
amounts of NO in response to cytokine stimulation (Rals-
ton, unpublished data). Monocultures of UMR 106 cells
produced low levels of NO2 (mean 6 SEM 5 0.5 6 0.25
mM), and this was not significantly increased by the cyto-
kine cocktail (0.75 6 0.30 mM; p 5 NS). Furthermore,
cocultures of UMR 106 cells and murine bone marrow cells
produced only marginally more NO than bone marrow cells
alone in response to stimulation with the cytokine cocktail
(10 6 3 mM vs. 8 6 2 mM; p 5 NS) and in these cultures,
the cytokine cocktail did not stimulate apoptosis (data not
shown).
The importance of NO, rather than cytokines, as the
mediator of apoptosis was further emphasized by experi-
ments in which apoptosis was measured in response to
stimulation with individual cytokines and combinations of
two or more cytokines in the presence and absence of
L-NMMA. Here we found a close correlation (r 5 0.885;
p , 0.01) between the number of apoptotic cells and the
concentrations of NO achieved after cytokine stimulation
(Fig. 6). When the cocultures were stimulated with single
cytokines, only IFN-g stimulated apoptosis. The combina-
tion of IL-1 and TNF-a did not induce apoptosis, whereas
FIG. 2. Effect of cytokine-induced NO on bone resorption
at different stages of osteoclast development. Cocultures were
performed on dentine slices (b, c) or in 48-well tissue culture
plates (a). The cytokine mix (IL-1, 10 U/ml; TNF, 25 ng/ml;
IFN, 100 U/ml) with or without 1 mM L-NMMA, was added
at day 4 or day 7. Medium in cultures that were cytokine
stimulated on day 4 was replaced with fresh medium on day 7
which did not contain cytokines, and NOS activity was inhib-
ited with 1 mM L-NMMA for the remaining 3 days (days
7–10). In all cultures, resorption area and osteoclast numbers
(number of TRAP positive cells) were measured on termina-
tion of the experiments at day 10. The results shown are from
a representative experiment from at least three performed,
with five replicates per group. *p , 0.05, **p , 0.01 from no
cytokines, 11p , 0.01 from no L-NMMA.
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the combination of IFN-g with IL-1 resulted in a moderate
induction of apoptosis, and the combination of TNF-a and
IFN-g resulted in apoptosis levels comparable to those in
cocultures treated with the full cytokine cocktail. Experi-
ments performed in the presence of the NO inhibitor L-
NMMA showed low levels of apoptosis, in keeping with the
data presented in Figs. 3–5.
To determine whether high concentrations of NO alone
were sufficient to induce apoptosis, we treated the cocul-
tures with the pharmacological NO donors S-nitroso-acetyl-
penicillamine (SNAP) and sodium nitroprusside (SNP).
While neither agent was sufficient to induce apoptosis on its
own in concentrations of up to 500 mM (equivalent to
medium NO2 levels of .100 mM), both NO donors re-
versed the inhibitory effects of L-NMMA on apoptosis in
cocultures stimulated with the cytokine cocktail (represen-
tative experiment with SNAP; Fig. 7).
These data strongly suggest that it is cytokine-induced
NO, rather than the cytokines themselves, or other osteo-
blast-released factors that mediate apoptosis of bone mar-
row cells in the coculture system. While these experiments
confirm that NO is essential for cytokine-induced apoptosis
of osteoclast precursors, they also show that NO donors
alone are insufficient to induce apoptosis, at least at con-
centrations which deliver NO at levels equivalent to those
resulting from cytokine stimulation. This suggests that the
proapoptotic effects of NO in this system may be enhanced
in the context of a cytokine induced costimulus.
Bone marrow cells are the main target for
NO-induced apoptosis
To confirm that bone marrow-derived cells were indeed
the main target for apoptosis, we performed cocultures
where only one of the cell populations was prelabeled with
BrdU and measured DNA fragmentation (reflecting apo-
ptosis) using an ELISA (Fig. 8). When only the osteoblasts
were prelabeled with BrdU, no increase in DNA fragmen-
tation was detected after cytokine stimulation, whereas a
large increase was observed when the bone marrow cells
were labeled, almost identical to that when both popula-
tions were labeled. This indicates that the vast majority of
apoptotic cells in the coculture are derived from the bone
marrow population. Labeling of apoptotic cells using the
TUNEL method also showed that immature cells in the
bone marrow population were the main target for apopto-
sis. In cocultures that were exposed to cytokines at an early
stage (days 2–4), a high percentage of the nonadherent bone
marrow cells were labeled (mean 6 SEM 5 63 6 3.7%,
compared with 6 6 1%; p , 0.007) in the unstimulated control
cultures. In contrast, very few osteoblasts (,1%) were labeled
by TUNEL staining after cytokine stimulation.
Although the presence of apoptotic cells in the nonad-
herent cell population does not completely exclude the
possibility that some of these cells may have derived from
the osteoblast layer, this seems extremely unlikely, taking
into account the results of the selective BrdU labeling
experiments (Fig. 8), the absence of apoptosis in osteoblast
monocultures (see above), and the fact that the large in-
crease in apoptotic cells observed in the cocultures (63% of
2 3 105 cells) far exceeds the total number of osteoblasts
present in the cultures.
It was also of interest that very few labeled mature oste-
oclasts were seen in cocultures stimulated with cytokines
during the later stages (days 7–10), suggesting that imma-
ture cells present in the bone marrow cell population are
the primary target for NO-induced apoptosis in this system,
rather than mature, fully differentiated osteoclasts.
DISCUSSION
This study shows that both osteoclast formation and the
activity of mature osteoclasts is inhibited by high levels of
cytokine-induced NO and that the decreased osteoclast
formation, in turn, is almost certainly due to NO-induced
FIG. 3. Cytokine-stimulated NO production causes apoptosis of bone marrow cells in cocultures. Osteoblasts and bone
marrow cells were cocultured for 3 days, stimulated with a cytokine mix (IL-1, 10 U/ml; TNF, 25 ng/ml; IFN, 100 U/ml)
and the experiment terminated after a further 48 h. (a) Phase contrast photomicrograph of unstimulated culture, showing
healthy bone marrow cells. The osteoblast layer below (slightly out of focus) remains intact. (b) Parallel culture stimulated
with the cytokine mix. Compared with the control culture, the stimulated culture contains a large number of shrunken cells
and cell fragments (arrowheads). The underlying osteoblast layer remains intact. (c) Parallel culture stimulated with the
cytokine cocktail in the presence of 1 mM L-NMMA, showing reversal of the effects of the cytokine mix on cell morphology
by L-NMMA. Again, the underlying osteoblast layer remains intact. The results shown are from a representative
experiment from at least three performed, with three replicates per group.
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apoptosis of osteoclast progenitors. These data agree with
previous experiments which have shown that high levels of
NO inhibit bone resorption in organ cultures of bone(7,9)
and in cultures of mature osteoclasts.(8,10,11) The absence of
apoptosis in previous studies of bone organ cultures and in
cultures of mature osteoclasts exposed to high concentra-
tions of NO induced by cytokines(7–11) supports our data
which show that immature cells in the bone marrow popu-
lation are the main target for NO-induced apoptosis, rather
than mature osteoclasts or osteoblasts. This is in keeping
with the observation that highly proliferative cells, like os-
teoclast progenitors, are much more susceptible to apopto-
sis than differentiated cells(14,15) like mature osteoclasts.
The failure of L-NMMA to completely restore bone resorp-
tion and osteoclast formation to control levels was probably
attributable to the fact that NO production could not be
completely inhibited, even by high concentrations of L-
NMMA, especially when cytokines were added early during
the culture period. While inhibition of bone resorption also
occurred when high levels of NO were induced during the
later stages of culture, this effect appeared to be due, in
part, to inhibition of resorption by mature osteoclasts, as
manifest by the marked reduction in pit formation, in the
presence of a significant increase in osteoclast numbers. We
found no evidence, either on morphological grounds or on
TUNEL staining, to suggest that high levels of cytokine-in-
duced NO caused mature osteoclasts to undergo apoptosis.
Although it has been suggested that constitutive produc-
tion of NO may be important in regulating osteoclast activ-
ity,(8,11) we found no effect of the NOS inhibitor L-NMMA
on osteoclast numbers or pit formation in unstimulated
cultures. From this we can conclude that in this system at
FIG. 5. Cytokine-induced apoptosis only occurs in cocul-
tures. Osteoblast cultures, bone marrow cultures, and co-
cultures were stimulated on day 3 with a cytokine mix
(cocktail) of IL-1 (10 U/ml) 1 TNF (25 ng/ml) 1 IFN (100
U/ml) in the presence and absence of L-NMMA (1 mM).
Apoptosis was quantitated 48 h after cytokine stimulation,
using a DNA fragmentation ELISA (see Methods). The
results shown are from a representative experiment from at
least three performed, with three replicates per group. *p ,
0.05, **p , 0.01 from no cytokines, 11p , 0.01 from no
L-NMMA; n 5 3.
FIG. 4. Confirmation of NO-mediated cytokine-induced ap-
optosis in bone marrow cells by TUNEL staining and electron
microscopy. Osteoblasts and bone marrow cells were cocul-
tured for 3 days and subsequently stimulated with a cytokine
mix (IL-1, 10 U/ml; TNF, 25 ng/ml; IFN, 100 U/ml). Nonad-
herent cells were harvested 24 h after stimulation by aspiration
of the wells and stained using the TUNEL method (a) and (c)
or analyzed by transmission electron microscopy (e). (a) Con-
trol cultures, TUNEL stain; (b) phase contrast image of (a);
(c) parallel cytokine stimulated culture, TUNEL stained,
showing an increase in labeled stained cells; (d) phase contrast
image of (c); (e) electron micrograph of cytokine stimulated
culture, showing fragmented and condensed nucleus with loss
of normal chromatin structure, condensed cytoplasm and in-
tact organelles and cell membrane. The results shown are
from a representative experiment from at least three per-
formed, with three replicates per group. Overall, the percent-
age of TUNEL labeled apoptotic cells was much greater in
cytokine-stimulated cultures (c) than in control cultures
(mean 6 SEM 5 63 6 7% vs. 6 6 1%, p , 0.007).
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least, constitutive production of NO plays a limited role in
regulating osteoclast formation and activity.
It is of interest that early osteoclast progenitor cells
present within the bone marrow cell fraction appeared to be
an important target for the proapoptotic effects of cytokine-
induced NO. Apoptosis was not increased in the osteoblast
layer on exposure to high concentrations of cytokine-in-
duced NO, and apoptosis in single cultures of bone marrow
cells was inhibited upon exposure to the cytokine mix. In
agreement with our data, high levels of IFN-g and TNF-a
induced NO have been shown to inhibit proliferation of
human bone marrow cells,(16) and this inhibitory effect has
been partially attributed to NO-induced apoptosis.(17) The
fact that cytokines reduced apoptosis in bone marrow cell
monocultures may be attributed to a positive effect of
cytokines on bone marrow cell survival, coupled with the
fact that monocultures of bone marrow cells produced only
a small amount of NO after cytokine stimulation.
Osteoblasts appeared to be the main producers of NO in
this system, since the rate of NO production in monocul-
tures of osteoblasts was over 100 times greater than that of
bone marrow cell cultures and almost as great as in the
cocultures. Although it is possible that bone marrow cells
could have acquired the ability to produce NO at a later
stage in the culture period as they differentiated into
more mature cells, the contribution of bone marrow
cell– derived NO is likely to be small, since the total levels
of NO produced in response to cytokines did not increase
substantially with time during the later stages of the
culture.
The fact that osteoblasts acted as the main source of NO
is relevant to previous studies, which have shown that many
osteotropic factors do not act directly on osteoclasts, but
rather act indirectly by inducing production of substances
by osteoblasts which then influence osteoclast formation
and activity.(18) The osteoblast-produced substances are
poorly defined, but, like NO, are thought to be small,
diffusible molecules which act over short distances between
FIG. 6. Correlation between cytokine-induced NO levels
and apoptosis in cocultures. BrdU labeled osteoblasts and
bone marrow cells were cocultured for 3 days and stimu-
lated with cytokines (IL-1, 10 U/ml; TNF, 25 ng/ml; IFN,
100 U/ml), alone and in combination as indicated in the
presence or absence of L-NMMA. Apoptosis was quanti-
tated 48 h after cytokine stimulation, using the DNA frag-
mentation ELISA as described in the text. The line in the
graph represents the calculated linear regression line of the
combined experiments each of which was run with three to
five replicates per treatment group.
FIG. 7. NO is essential but not sufficient to induce apo-
ptosis in cocultures. BrdU-labeled osteoblasts and bone
marrow cells were cocultured for 3 days and stimulated with
a cytokine mix (cocktail) of IL-1 (10 U/ml) 1 TNF (25
ng/ml) 1 IFN (100 U/ml) alone and in combination with
SNAP (300 mM) and/or L-NMMA (1 mM). Apoptosis was
quantitated using a DNA fragmentation ELISA as de-
scribed in the text. The results shown are from a represen-
tative experiment from at least three performed, with four
replicates per group. **p , 0.01 from control, SNAP and
cocktail/L-NMMA groups.
FIG. 8. Bone marrow cells are the main target for NO-
induced apoptosis. Cocultures were set up in which the cell
populations were individually labeled with BrdU and then
cytokine stimulated with a mix of IL-1 (10 U/ml) 1 TNF (25
ng/ml) 1 IFN (100 U/ml). BM, bone marrow cells BrdU
labeled; Ob, osteoblasts BrdU labeled; both, bone marrow
cells and osteoblasts BrdU labeled. Apoptosis was quanti-
tated 24 h after cytokine stimulation by a DNA fragmenta-
tion ELISA as described in the text. Cytokine-induced in-
creases in DNA fragmentation were detected by the ELISA
only when bone marrow cells were prelabeled with BrdU
and the amount of fragmentation was identical to that
obtained when both cell populations were BrdU labeled,
indicating that cytokine-induced DNA fragmentation (re-
flecting apoptosis) predominantly occurs in the bone mar-
row population. The results shown are from a representa-
tive experiment from at least three performed, with four
replicates per group. **p , 0.01 from control cultures.
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cells which are in close contact. The coculture system used
here now shows that cytokine-induced NO released from
osteoblasts can act directly in a relatively selective fashion
to down-regulate osteoclast formation and activity, thereby
identifying NO as a potentially important osteoblast–oste-
oclast coupling factor.
The importance of NO as a mediator of cytokine-induced
apoptosis of osteoclast precursors is supported by the ob-
servation that the effect could be largely reversed by inhi-
bition of NOS with L-NMMA. However, experiments using
the NO donors SNAP and SNP showed that these agents
alone cannot induce apoptosis, at least at concentrations
that deliver NO at equivalent levels to those which result
from cytokine stimulation. This indicates that while high
levels of NO are necessary to trigger apoptosis in this
situation, they are not sufficient to do so and must be delivered
in the context of a cytokine costimulus. This in turn implies
that NO may interact with cytokine-induced signaling path-
ways in bone to induce apoptosis, although the nature of these
interactions will require further research.
In summary, high levels of osteoblast-produced NO in-
hibit bone resorption by two mechanisms: first, by inducing
apoptosis of osteoclast progenitors present in the bone
marrow cell population, and second, by inhibiting the re-
sorptive activity of mature osteoclasts. The first mechanism
accounts for the potent inhibitory effect of cytokines on
osteoclast formation during the early stages of the cocul-
ture, whereas the second mechanism is important during
the later stages where we observed increased osteoclast
numbers, but decreased resorption, indicating less resorp-
tion per osteoclast. The former mechanism is in keeping
with previous observations which have shown an absence of
osteoclasts in bone organ cultures treated with IL-1, TNF,
and IFN, and the latter with the observation that NO donors
inhibit resorption by mature isolated osteoclasts.(10,11)
These studies confirm that NO is a potent inhibitor of
bone resorption with effects on both osteoclast formation
and activity. Pharmacological modulation of NO may there-
fore represent a new approach in the treatment of bone
diseases characterized by increased bone resorption, such
as osteoporosis, rheumatoid arthritis, and cancer-associated
osteolysis.
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